ArticleScientific reports2025
White adipose tissues and skeletal muscles as a target of chrysin during the treatment of obesity in rats.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Preclinical evidence of chrysin in metabolic disorder via mitochondrial signaling: a mechanistic review.Molecular biology reports · 2026Review
- Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights-A Scoping Review.Nutrients · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is a rapidly growing epidemic that continues to be a major severe health problem due to its association with various adverse health consequences. Since 1975, the WHO estimates that the prevalence of obesity has tripled globally. Chrysin is a flavone that is mostly found in the Passiflore species of plants and in propolis. The present study was conducted to examine the anti-obesity effect of chrysin on a high-fat diet-induced obesity in rats and to compare their impact to physical activity (swimming). Rats were classified into two groups: the control group and the obese group, which was subdivided into 4 subgroups (8 rats each); an untreated obese group; a chrysin-treated group (oral dose of 100 mg/kg/day); swimming-treated groups (swimming for 1 h/day, five days/week with a constant overload equal to 5% of their weight); and combination-treated groups (chrysin and swimming). After 8 weeks of treatment, blood samples were taken at the end of the experiment for biochemical tests. Animals were then slaughtered to get white adipose tissue (WAT) and skeletal muscle for analysis of the gene expression of the studied genes. In obese rats, therapy with chrysin reduced weight gain, hyperglycaemia, and insulin resistance. Also, the effects of chrysin may be mediated through acting as an anti-inflammatory and antioxidative stress agent. Physical activity (swimming) is a more efficient anti-obesity agent than treating with chrysin alone through upregulation of PPAR-γ and downregulation of Mir-27a. Physical activity with daily supplementation of chrysin showed the best efficiency for the treatment of obesity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.